Ajanta Pharma Q3 net up 76% at 32.57 cr
Quotes

Ajanta Pharma Q3 net up 76% at 32.57 cr

Last Updated: Wednesday, January 23, 2013, 13:55
 
 Comment 0
 
Ajanta Pharma Q3 net up 76% at 32.57 cr
New Delhi: Drug company Ajanta Pharma on Wednesday reported 75.95 percent increase in net profit to Rs 32.57 crore for the third quarter ended December 31, 2012, mainly on robust sales.

The company had posted a net profit of Rs 18.51 crore for the corresponding period previous fiscal.

Net sales of the company rose to Rs 225.68 for the quarter under consideration from Rs 164.52 crore for the same period last fiscal, Ajanta Pharma said in a BSE filing.

"The company recently received market authorisation in UK for Slidenafil tablets 50 mg and 100 mg. Company expects to launch the same in UK when it goes off patent in June 2013," Ajanta Pharma said.

Shares of Ajanta Pharma were trading at Rs 490.65 apiece in the afternoon trade on the BSE, a steep 19.99 percent rise from their previous close.

PTI




First Published: Wednesday, January 23, 2013, 13:55


Comments


comments powered by Disqus
New York Auto Show: 2015 Subaru Outback
New York Auto Show: 2015 Subaru Outback
New York Auto Show: Dodge Hot Cars
New York Auto Show: Dodge Hot Cars
New York Auto Show 2014: Hot Cars
New York Auto Show 2014: Hot Cars
Top 10 Fastest-Emerging Cities
Top 10 Fastest-Emerging Cities
Top Businesswomen in India
Top Businesswomen in India

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved